• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人阻力动脉中收缩性内皮素和血管紧张素受体的特性:两种内皮素受体和一种血管紧张素受体的证据

Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor.

作者信息

Tschudi M R, Lüscher T F

机构信息

Department of Research, University Hospital Basel, Switzerland.

出版信息

Biochem Biophys Res Commun. 1994 Oct 28;204(2):685-90. doi: 10.1006/bbrc.1994.2514.

DOI:10.1006/bbrc.1994.2514
PMID:7980530
Abstract

Endothelin-1 (ET-1) and angiotensin II (AII) are potent vasoconstrictor hormones which regulate tissue perfusion and blood pressure. We pharmacologically characterized endothelin and angiotensin receptors mediating contractions of human mammary resistance arteries in myographs for isometric tension recording. ET-1 caused potent contractions. The concentration response curve was shifted to the right by ETA antagonist FR 139317, but a high sensitivity, low efficacy component remained. After incubation with ETB agonist sarafotoxin (S6c) this component of the concentration response curve resistant to FR 139317 disappeared. The ETA/ETB-receptor antagonist bosentan shifted the entire concentration response curve to the right. AI and AII caused marked contractions. The effects of AI were reduced by the ACE inhibitor benazeprilat, while those of AII were prevented by valsartan, an AT1 antagonist. In summary, in human resistance arteries, contractions to ET-1 are mediated by ETA- and ETB-receptors while those to AII are exclusively mediated by AT1-receptors.

摘要

内皮素-1(ET-1)和血管紧张素II(AII)是强效血管收缩激素,可调节组织灌注和血压。我们通过药理学方法对介导人体乳腺阻力动脉在肌张力记录肌动描记器中收缩的内皮素和血管紧张素受体进行了表征。ET-1引起强效收缩。ETA拮抗剂FR 139317使浓度-反应曲线右移,但仍保留一个高敏感性、低效能成分。在用ETB激动剂沙拉新(S6c)孵育后,浓度-反应曲线中对FR 139317耐药的这一成分消失。ETA/ETB受体拮抗剂波生坦使整个浓度-反应曲线右移。AI和AII引起明显收缩。ACE抑制剂贝那普利拉可降低AI的作用,而AT1拮抗剂缬沙坦可阻断AII的作用。总之,在人体阻力动脉中,ET-1引起的收缩由ETA和ETB受体介导,而AII引起的收缩仅由AT1受体介导。

相似文献

1
Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor.人阻力动脉中收缩性内皮素和血管紧张素受体的特性:两种内皮素受体和一种血管紧张素受体的证据
Biochem Biophys Res Commun. 1994 Oct 28;204(2):685-90. doi: 10.1006/bbrc.1994.2514.
2
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.ETA和ETB受体均可介导人血管对内皮素-1的收缩反应。
Circulation. 1994 Mar;89(3):1203-8. doi: 10.1161/01.cir.89.3.1203.
3
Vasoactivity mediated by endothelin ETA and ETB receptors in isolated porcine ophthalmic artery.
Acta Physiol Scand. 1996 Jun;157(2):245-52. doi: 10.1046/j.1365-201X.1996.499244000.x.
4
Comparison of the contractile effects and binding kinetics of endothelin-1 and sarafotoxin S6b in rat isolated renal artery.大鼠离体肾动脉中内皮素-1与芋螺毒素S6b的收缩效应及结合动力学比较
Br J Pharmacol. 1997 May;121(2):253-63. doi: 10.1038/sj.bjp.0701126.
5
ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.ETA和ETB受体介导衰老自发性高血压大鼠肾动脉对内皮素-1的收缩反应。FR139317和波生坦的作用。
Hypertension. 1995 Apr;25(4 Pt 1):501-6. doi: 10.1161/01.hyp.25.4.501.
6
Increased endothelin ETB contractile activity in cultured segments of human temporal artery.
Acta Physiol Scand. 1998 Sep;164(1):21-7. doi: 10.1046/j.1365-201X.1998.0399e.x.
7
Angiotensin II enhances responses to endothelin-1 in bovine bronchial smooth muscle.
Pulm Pharmacol. 1994 Dec;7(6):409-13. doi: 10.1006/pulp.1994.1048.
8
Endothelin receptor subtypes in small arteries. Studies with FR139317 and bosentan.小动脉中的内皮素受体亚型。使用FR139317和波生坦的研究。
Hypertension. 1995 Apr;25(4 Pt 2):739-43. doi: 10.1161/01.hyp.25.4.739.
9
Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat.
Fundam Clin Pharmacol. 1999;13(4):461-7. doi: 10.1111/j.1472-8206.1999.tb00004.x.
10
Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat.
Can J Physiol Pharmacol. 1998 Feb;76(2):141-7.

引用本文的文献

1
Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome.疑似急性冠脉综合征患者外周阻力动脉中内皮素ET(B)和血管紧张素AT(1)受体表达增加。
Heart Vessels. 2009 Nov;24(6):393-8. doi: 10.1007/s00380-008-1136-8. Epub 2009 Nov 22.
2
The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?内皮素系统作为心血管疾病的治疗靶点:厚望还是空想?
Br J Pharmacol. 2008 Mar;153(6):1105-19. doi: 10.1038/sj.bjp.0707516. Epub 2007 Oct 29.
3
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
使用BQ-123进行全身性ETA受体拮抗可阻断ET-1诱导的健康男性前臂血管收缩,并降低外周血管阻力。
Br J Pharmacol. 2001 Oct;134(3):648-54. doi: 10.1038/sj.bjp.0704304.
4
Endothelin in cardiovascular control: the role of endothelin antagonists.内皮素在心血管调控中的作用:内皮素拮抗剂的角色
Curr Hypertens Rep. 1999 Feb-Mar;1(1):79-87. doi: 10.1007/s11906-999-0077-7.
5
Endothelial dysfunction: the role and impact of the renin-angiotensin system.内皮功能障碍:肾素-血管紧张素系统的作用与影响
Heart. 2000 Sep;84 Suppl 1(Suppl 1):i20-2:discussion i50. doi: 10.1136/heart.84.suppl_1.i20.
6
The mechanism of cryoinjury: In vitro studies on human internal mammary arteries.冷冻损伤的机制:关于人乳内动脉的体外研究
Br J Pharmacol. 2000 Jun;130(3):636-40. doi: 10.1038/sj.bjp.0703326.
7
Valsartan. A review of its pharmacology and therapeutic use in essential hypertension.缬沙坦。其药理学及在原发性高血压治疗应用的综述。
Drugs. 1997 Aug;54(2):299-311. doi: 10.2165/00003495-199754020-00009.
8
Endothelial dysfunction and hypertension.内皮功能障碍与高血压。
Drugs. 1997;53 Suppl 1:30-41. doi: 10.2165/00003495-199700531-00006.
9
Plasticity of contractile endothelin-B receptors in human arteries after organ culture.器官培养后人动脉中收缩性内皮素-B受体的可塑性
Br J Pharmacol. 1996 Nov;119(6):1159-66. doi: 10.1111/j.1476-5381.1996.tb16018.x.
10
The clinical potential of endothelin receptor antagonists in cardiovascular medicine.内皮素受体拮抗剂在心血管医学中的临床潜力。
Drugs. 1996 Jan;51(1):12-27. doi: 10.2165/00003495-199651010-00003.